bNeural stem cells (NSCs) continually generate functional neurons in the adult brain. Due to their ability to proliferate, deregulated NSCs or their progenitors have been proposed as the cells of origin for a number of primary central nervous system neoplasms, including infiltrating gliomas. The orphan nuclear receptor TLX is required for proliferation of adult NSCs, and its upregulation promotes brain tumor formation. However, it is unknown whether TLX is required for gliomagenesis. We examined the genetic interactions between TLX and several tumor suppressors, as well as the role of TLX-dependent NSCs during gliomagenesis, using mouse models. Here, we show that TLX is essential for the proliferation of adult NSCs with a single deletion of p21, p53, or Pten or combined deletion of Pten and p53. While brain tumors still form in Tlx mutant mice, these tumors are less infiltrative and rarely associate with the adult neurogenic niches, suggesting a non-stem-cell origin. Taken together, these results indicate a critical role for TLX in NSC-dependent gliomagenesis and implicate TLX as a therapeutic target to inhibit the development of NSC-derived brain tumors.
The subgranular zone (SGZ) of the dentate gyrus (DG) and the subventricular zone (SVZ) of the lateral ventricle (LV) are the two neurogenic niches in the adult brain where neural stem cells (NSCs) reside and continually produce functional neurons (12,24,39). The orphan nuclear receptor TLX (also known as NR2E1) regulates proliferation in these NSCs by modulating the expression of Pten, p21, and several other genes downstream of p53 (17,18,26,32,46). However, the genetic interactions between TLX and these genes have not been examined.The characteristic self-renewal of NSCs renders them prone to mutation, deregulated proliferation, and differentiation, all hallmarks of neoplasms in the central nervous system (CNS). Indeed, emerging evidence indicates that NSCs are the cellular origin of gliomas (1, 43, 48). Mutagenesis through viral or chemical carcinogens preferentially induces brain tumors in the vicinity of the neurogenic niche (4,5,14,27). These results were further corroborated with the recent development of mouse models that are induced by mutation of the tumor suppressor p53, Pten, Nf1, Rb, or Ink4a/Arf or activation of the oncogene Ras, Akt, or Egfr (1,11,21,43,48,49). As a key regulator of NSC proliferation, it is not surprising that TLX has been implicated in gliomagenesis. When combined with inactivation of p53 or Ink4a/Arf, ectopic expression of TLX is sufficient for glioma formation in a mouse model (18, 28). However, whether TLX is required for gliomagenesis or tumor maintenance is not known. Furthermore, the relationship between gliomagenesis and normal adult neurogenesis requires additional investigation. Here, we examined the role of TLX and TLX-dependent NSCs in a mouse model of gliomagenesis.
MATERIALS AND METHODSAnimals. Strategies and methods for generating the following mutant mice have been described:, and hGfap-Cre (50) mice. All mice were...